Virginia Steen

Featured in: Favicon

biomedcentral.com Favicon

healio.com Favicon

jimmunol.org Favicon

jrheum.org Favicon

onlinelibrary.wiley.com Favicon

ard.bmj.com Favicon

arthritis-research.biomedcentral.com

Articles

Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II.

May 7, 2024 | digitalcommons.library.tmc.edu | Elizabeth R Volkmann |Virginia Steen |Ning Li |Michael Roth

OBJECTIVE: To evaluate short- and long-term outcomes of African American (AA) participants of Scleroderma Lung Studies (SLS) I and II. METHODS: SLS I randomized 158 participants with systemic sclerosis-interstitial lung disease (SSc-ILD) to 1 year of oral cyclophosphamide (CYC) versus placebo. SLS II randomized 142 participants with SSc-ILD to 1 year of oral CYC followed by 1 year of placebo versus 2 years of mycophenolate (MMF).

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →